oncology medicine targeted therapy her2 egfr inhibitor

💊 Herduo 250 mg Tablet (30’s Pack) | Lapatinib | Breast Cancer Treatment | Export Supplier Herduo 250 mg Tablet contains Lapatinib, a targeted anticancer medicine used in the treatment of HER2-positive breast cancer. It works by inhibiting HER2 and EGFR receptors, helping to slow tumor growth and progression. 🔹 Product Category Oncology Medicine (Targeted Therapy / HER2 & EGFR Inhibitor) 🔹 Composition Lapatinib 250 mg 🔹 Indications ✔ HER2-Positive Breast Cancer ✔ Advanced or Metastatic Breast Cancer 🔹 Key Benefits ✔ Dual-targeted therapy (HER2 & EGFR) ✔ Effective in advanced-stage breast cancer ✔ Oral treatment (patient-friendly) ✔ Used in combination with other therapies 🔹 Dosage & Administration ✔ Oral tablet as prescribed ✔ Usually taken on an empty stomach ✔ Dosage based on treatment protocol ✔ Under strict medical supervision 🔹 Packaging ✔ 30 Tablets Pack ✔ Blister / Bottle Packaging ✔ Bulk Export Available ✔ Private Labeling Supported 🔹 Certifications ✔ WHO-GMP Certified ✔ COA & COPP Available 🌍 Target Export Markets & Cities 🇺🇸 USA: New York, Los Angeles, Houston 🇬🇧 UK: London, Manchester 🇦🇪 UAE: Dubai, Abu Dhabi 🇸🇬 Singapore: Singapore 🇮🇳 India: Mumbai, Delhi, Bangalore 🇵🇭 Philippines: Manila 🇻🇳 Vietnam: Ho Chi Minh City, Hanoi 🇿🇦 South Africa: Johannesburg, Cape Town 🇳🇬 Nigeria: Lagos, Abuja 🇰🇪 Kenya: Nairobi 🇧🇷 Brazil: São Paulo 🇲🇽 Mexico: Mexico City 🇵🇪 Peru: Lima 📍 Location: Nagpur, Maharashtra, India 📦 Product Catalogue Available ✔ Oncology Medicines ✔ HIV & Antiviral Medicines ✔ Specialty Pharmaceutical Products 📞 Instant Support – Call / WhatsApp Now 📲 +91 8007161282 📲 +91 9970011496 💬 Quick replies for urgent orders & inquiries! 🌐 Visit Our Official Websites 🔹 www.pacificmedicines.com 🔹 www.indocares.com 🔹 www.indiamedexport.com 📧 Business Enquiries & Bulk Orders ✉️ sales@pacificmedicines.com